Do EASL and mRECIST responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization?
- PMID: 22326644
- DOI: 10.1016/j.jhep.2012.01.016
Do EASL and mRECIST responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization?
Comment on
-
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.J Hepatol. 2011 Dec;55(6):1309-16. doi: 10.1016/j.jhep.2011.03.007. Epub 2011 Apr 15. J Hepatol. 2011. PMID: 21703196
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
